- Home
- PRQR vs AEF Comparison
PRQR vs AEF Comparison
Compare PRQR & AEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- AEF
- Stock Information
- Founded
- PRQR 2012
- AEF 1989
- Country
- PRQR Netherlands
- AEF United States
- Employees
- PRQR N/A
- AEF N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- AEF Finance/Investors Services
- Sector
- PRQR Health Care
- AEF Finance
- Exchange
- PRQR Nasdaq
- AEF Nasdaq
- Market Cap
- PRQR 244.4M
- AEF 237.5M
- IPO Year
- PRQR 2014
- AEF N/A
- Fundamental
- Price
- PRQR $2.17
- AEF $6.10
- Analyst Decision
- PRQR Strong Buy
- AEF
- Analyst Count
- PRQR 8
- AEF 0
- Target Price
- PRQR $8.88
- AEF N/A
- AVG Volume (30 Days)
- PRQR 201.7K
- AEF 92.5K
- Earning Date
- PRQR 08-07-2025
- AEF 01-01-0001
- Dividend Yield
- PRQR N/A
- AEF 7.13%
- EPS Growth
- PRQR N/A
- AEF N/A
- EPS
- PRQR N/A
- AEF 0.57
- Revenue
- PRQR $20,129,184.00
- AEF N/A
- Revenue This Year
- PRQR N/A
- AEF N/A
- Revenue Next Year
- PRQR N/A
- AEF N/A
- P/E Ratio
- PRQR N/A
- AEF $8.86
- Revenue Growth
- PRQR 8.65
- AEF N/A
- 52 Week Low
- PRQR $1.07
- AEF $4.40
- 52 Week High
- PRQR $4.62
- AEF $5.53
- Technical
- Relative Strength Index (RSI)
- PRQR 51.89
- AEF 59.04
- Support Level
- PRQR $2.16
- AEF $5.96
- Resistance Level
- PRQR $2.15
- AEF $6.16
- Average True Range (ATR)
- PRQR 0.14
- AEF 0.08
- MACD
- PRQR -0.03
- AEF -0.02
- Stochastic Oscillator
- PRQR 42.11
- AEF 53.85
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
About AEF abrdn Emerging Markets Equity Income Fund Inc.
ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. is a closed-end investment company. The Fund's investment objective is to seek to provide both current income and long-term capital appreciation. The Fund invests in a range of sectors, including financials, consumer staples, utilities, consumer discretionary, materials, energy, information technology, private equity, communication services, healthcare, real estate, and industrials.